Jian-jun Li

Nanning, 530007, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

CapeOx -HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter propensity score-matched analysis.

CapeOx -HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter propensity score-matched analysis.

Journal: Surgical oncology

Published: January 07, 2026

Multimodal analysis reveals potential association of CDH13 with endothelial cells and its overexpression in hepatocellular carcinoma.

Multimodal analysis reveals potential association of CDH13 with endothelial cells and its overexpression in hepatocellular carcinoma.

Journal: European journal of medical research

Published: July 11, 2025

From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment.

From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment.

Journal: Human vaccines & immunotherapeutics

Published: January 06, 2025

Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma.

Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma.

Journal: World journal of hepatology

Published: May 25, 2024

Clinical Significance of Upregulation of EZH1 Expression in Hepatocellular Carcinoma Tissues.

Clinical Significance of Upregulation of EZH1 Expression in Hepatocellular Carcinoma Tissues.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: August 25, 2023

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments.

LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments.

Journal: Cancer medicine

Published: October 26, 2022

Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma.

Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma.

Journal: Digestive diseases and sciences

Published: August 06, 2022

A cohesin-associated gene score may predict immune checkpoint blockade in hepatocellular carcinoma.

A cohesin-associated gene score may predict immune checkpoint blockade in hepatocellular carcinoma.

Journal: FEBS open bio

Published: March 18, 2022

Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues.

Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues.

Journal: Bioengineered

Published: August 09, 2021

Correction to: Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study.

Correction to: Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study.

Journal: Cancer cell international

Published: February 29, 2020

Upregulated expression of SAC3D1 is associated with progression in gastric cancer.

Upregulated expression of SAC3D1 is associated with progression in gastric cancer.

Journal: International journal of oncology

Published: July 19, 2019

EBV as a potential risk factor for hepatobiliary system cancer: A meta-analysis with 918 cases.

EBV as a potential risk factor for hepatobiliary system cancer: A meta-analysis with 918 cases.

Journal: Pathology, research and practice

Published: August 02, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026